Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:antilipemic drug
go back to main search page
Accession:CHEBI:35679 term browser browse the term
Definition:A substance used to treat hyperlipidemia (an excess of lipids in the blood).
Synonyms:related_synonym: antihyperlipemic;   antihyperlipemics;   antihyperlipidemic;   antihyperlipidemic agent;   antihyperlipidemic agents;   antihyperlipidemic drug;   antihyperlipidemic drugs;   antihyperlipidemics;   antilipemic;   antilipemic drugs;   antilipemics;   hypolipidemic agent;   hypolipidemic agents
 xref: Wikipedia:Hypolipidemic_agent


show annotations for term's descendants       view all columns           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19728
    role 19675
      application 19328
        pharmaceutical 19202
          drug 19202
            antilipemic drug 6369
              (+)-schisandrin B 2218
              (R)-carnitine + 76
              3-pyridinemethanol 1
              D-psicose + 0
              FR177391 0
              anticholesteremic drug + 3890
              berberine 204
              bezafibrate 218
              cerulenin 13
              ciprofibrate 138
              clofibrate 2655
              clofibric acid + 3064
              diallyl trisulfide 192
              ethionamide + 17
              ethionamide S-oxide 0
              ezetimibe 19
              fenofibrate 661
              fluvastatin sodium 0
              fucoidan 23
              gemfibrozil 93
              loteprednol + 2
              marsupsin 0
              monascin 17
              nafenopin 18
              naringenin 7-O-beta-D-glucoside 0
              nicotinic acid + 244
              perfluorooctane-1-sulfonic acid + 1663
              probucol 43
              rosuvastatin 1
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.